Targeting Aurora Kinases: A Novel Approach to Curb the Growth & Chemoresistance of Androgen Refractory Prostate Cancer (Englisch)
- Neue Suche nach: Jeet, V.
- Neue Suche nach: J. Russell, P.
- Neue Suche nach: D. Verma, N.
- Neue Suche nach: Khatri, A.
- Neue Suche nach: Jeet, V.
- Neue Suche nach: J. Russell, P.
- Neue Suche nach: D. Verma, N.
- Neue Suche nach: Khatri, A.
In:
Current Cancer Drug Targets
;
12
, 2
;
144-163
;
2012
-
ISSN:
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:Targeting Aurora Kinases: A Novel Approach to Curb the Growth & Chemoresistance of Androgen Refractory Prostate Cancer
-
Weitere Titelangaben:CCDT
-
Beteiligte:Jeet, V. ( Autor:in ) / J. Russell, P. ( Autor:in ) / D. Verma, N. ( Autor:in ) / Khatri, A. ( Autor:in )
-
Erschienen in:Current Cancer Drug Targets ; 12, 2 ; 144-163
-
Verlag:
- Neue Suche nach: Bentham Science Publishers Ltd.
-
Erscheinungsdatum:01.03.2012
-
Format / Umfang:20 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Schlagwörter:Aurora kinases , Cancer , chemotherapy , combination therapy , docetaxel , prostate cancer , targeted molecular therapy , Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP) , Androgen Sensitive , Androgen Depletion Independent , Combination Index , Dose Reduction Index , Horse Radish Peroxidase , Harris' Hematoxylin and Eosin , Inner Centromere Protein , Oncology
-
Datenquelle:
Inhaltsverzeichnis – Band 12, Ausgabe 2
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 85
-
The Cyclin-Dependent Kinase Inhibitor p21CDKN1A as a Target of Anti-Cancer DrugsA. Stivala, L. / Cazzalini, O. / Prosperi, E. et al. | 2012
- 97
-
Gamma-Amino Butyric Acid Inhibits the Nicotine-Imposed Stimulatory Challenge in Xenograft Models of Non-Small Cell Lung CarcinomaA.N. Al-Wadei, H. / H. Al-Wadei, M. / F. Ullah, M. / M. Schuller, H. et al. | 2012
- 107
-
Adding to the Mix: Fibroblast Growth Factor and Platelet-Derived Growth Factor Receptor Pathways as Targets in Non – small Cell Lung CancerA. Kono, S. / E. Heasley, L. / C. Doebele, R. / R. Camidge, D. et al. | 2012
- 124
-
Analysis of the Concordance in the EGFR Pathway Status Between Primary Tumors and Related Metastases of Colorectal Cancer Patients:Implications for Cancer TherapyCejas, P. / Lopez-Gomez, M. / Aguayo, C. / Madero, R. / Moreno-Rubio, J. / de Castro Carpeno, J. / Belda-Iniesta, C. / Barriuso, J. / Moreno Garcia, V. / Diaz, E. et al. | 2012
- 132
-
Characterization of the Prostaglandin E2 Pathway in a Rat Model of Esophageal AdenocarcinomaPiazuelo, E. / Santander, S. / Cebrian, C. / Jimenez, P. / Pastor, C. / A. Garcia-Gonzalez, M. / Esteva, F. / Esquivias, P. / Ortego, J. / Lanas, A. et al. | 2012
- 144
-
Targeting Aurora Kinases: A Novel Approach to Curb the Growth & Chemoresistance of Androgen Refractory Prostate CancerJeet, V. / J. Russell, P. / D. Verma, N. / Khatri, A. et al. | 2012
- 164
-
Transplacental Antioxidants Inhibit Lung Tumors in Mice Exposed to Cigarette Smoke After Birth: A Novel Preventative Strategy?Balansky, R. / Ganchev, G. / Iltcheva, M. / E. Steele, V. / De Flora, S. et al. | 2012
- 170
-
Anticancer Drugs Aimed at E6 and E7 Activity in HPV-Positive Cervical CancerTan, S. / G.E. de Vries, E. / G.J. van der Zee, A. / de Jong, S. et al. | 2012